Skin cancer of the head and neck comprise a heterogeneous mix of tumors with differing treatment response and outcomes depending upon histology. We present a large retrospective analysis of these tumors treated in a single institution over a 21-year period. We present the results of patients treated with surgery and/or radiation for Merkel Cell Carcinoma (MCC), melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).
S. Rice, E. Liang, H. Geye & R.J. Kimple.
Contact Us
The role of radiation in treating non-malignant diseases is currently undergoing an American Renaissance. Low-dose radiation therapy (LDRT) has been used successfully throughout the world for treating benign conditions for over a century, but its resurgence has been...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the AOCD 2024 meeting, in Scottsdale, AZ. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring. Visit Xstrahl at AOCD 2024, booth # 22 at the Westin Kierland from April 11-14, 2024.
Xstrahl's Medical Director, Dr. Richard Shaffer, recently spoke for a webinar hosted by Joint Pain Practice. He shares how low-dose radiotherapy can be used for osteoarthritis, and overviews the treatment process, risks, and efficacy. https://youtu.be/ab4iyfhN_L8...
